<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-344
Date of Submission: 2024-09-18

This report was submitted by a Nurse from Mckinney-Williams Medical Center concerning patient ANON-PX-3745. The subject is a 41-year-old male with a significant medical history including hypertension, anxiety. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin administered via the Subcutaneous route at a dosage of 364mg, initiated on 2024-07-29 for Neuropathic pain and discontinued on 2024-09-06.

On approximately 2024-08-11, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Headache, Hepatotoxicity. The Headache was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed development and advised break. The current patient status regarding this symptom is 'Not Recovered'. The Hepatotoxicity was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed hour and advised whose. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 6 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive rechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2024-344
report_date: '2024-09-18'
patient_details:
  patient_id: ANON-PX-3745
  gender: Male
  relevant_history:
  - hypertension
  - anxiety
  age_at_reaction: 41
suspected_drugs:
- drug_name: Gabapentin
  dosage: 364mg
  route_of_administration: Subcutaneous
  start_date: '2024-07-29'
  indication_for_use: Neuropathic pain
  end_date: '2024-09-06'
adverse_reactions:
- symptom_name: Headache
  onset_date: '2024-08-11'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed development and advised break.
- symptom_name: Hepatotoxicity
  onset_date: '2024-08-11'
  severity: Severe
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed hour and advised whose.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive rechallenge
  naranjo_score: 6
reporting_facility: Mckinney-Williams Medical Center
reporter_type: Nurse
